An overview of insulin therapy for the non‐specialist

Documents similaires

• An overview of randomized clinical trials of fixed‐ratio combinations of basal insulin plus GLP ‐ 1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes
  par: Geremia B. Bolli, et autres
  Publié: (2025)
• Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
  par: Nan Dai, et autres
  Publié: (2024)
• Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed‐ratio combinations of basal insulin and a glucagon‐like peptide‐1 receptor agonist
  par: Luděk Horváth, et autres
  Publié: (2025)
• Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
  par: Ajenthen G. Ranjan, et autres
  Publié: (2025)
• Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial
  par: Melissa‐Rosina Pasqua, et autres
  Publié: (2025)